1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSBIR Phase I — US Small Business Innovation is sponsored by US Federal Agencies (across 11 agencies). US federal funding for small businesses developing innovative technologies, including blockchain, AI, and quantum, with a clear path to commercialization.
Get alerted about grants like this
Get emailed when new opportunities from “US Federal Agencies (across 11 agencies)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: US-incorporated for-profit small businesses (under 500 employees, >50% US-owned). Principal investigator must be employed at the company at least 51% of the time. Foreign founders can incorporate a Delaware C-Corp and establish US operations to qualify. Confirm the full requirements in the official notice before applying.
The current listing shows up to $295,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
SBIR Phase I — US Small Business Innovation is funded by US Federal Agencies (across 11 agencies). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Delaware. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On July 22, 2026, the Department of Energy opened the first Phase I SBIR/STTR release tied to its Genesis Mission — roughly 40 awards across biotechnology, AI-for-quantum, predictable-materials design, and autonomous laboratories — alongside about $147M in FY25 Phase II funding. Here is what each topic area actually wants, who is eligible, how this connects to the $5B Genesis Mission, and how a small business should position before the broader fall solicitation.
Read articleOn May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleFoundation Source's 2026 Giving Outlook reports $1.6 billion distributed across 71,000+ grants to 27,000+ recipients through September 2025, with private foundation clients contributing $1.5B and DAFs $89M. Midsize foundation grantmaking rose 13.6% in 2024, general operating support climbed to 40.3%, and grants to non-501(c)(3) entities grew from $39M to $51M. With the OMB Uniform Grants Regulation rewrite poised to make discretionary federal awards more politically conditional, private philanthropy is becoming the most adaptive funding channel in the sector. Here is how to read the shift.
Read article